Class IIOngoing

Nicotinamide adenine dinucleotide (NAD+): 100mg/mL recall

FDA recall D-0487-2025 · initiated May 21, 2025

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Lack of Assurance of Sterility

Details

Product: Nicotinamide adenine dinucleotide (NAD+): 100mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112
Recalling company: Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)
Classification: Class II
Status: Ongoing
Type: Voluntary: Firm initiated
Distribution: USA Nationwide
Initiated: May 21, 2025
FDA report date: Jul 2, 2025

What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Source: openFDA Drug Enforcement record D-0487-2025 ↗

← All drug recalls